PremiumThe FlyMEI Pharma engages financial advisor to evaluate strategic alternatives MEI Pharma engages financial advisor to evaluate strategic alternatives MEI Pharma Explores Strategic Shifts, Leadership Changes PremiumCompany AnnouncementsMEI Pharma Announces Executive Changes and Strategic Overhaul MEI Pharma downgraded to Hold from Buy at Brookline MEI Pharma to evaluate strategic alternatives, reports departure of CEO and CMO PremiumCompany AnnouncementsMEI Pharma Announces Flexible $25 Million Funding Strategy MEI Pharma files $100M mixed securities shelf MEI Pharma price target lowered to $7 from $8 at Stifel